AdvisorShares Psychedelics ETF

Rentabilität für das Jahr: 30.74%
Kommission: 0.99%
Kategorie: Health & Biotech Equities
Name Industrie Aktie, % P/BV P/S P/E EV/Ebitda Dividendenrendite
#1 COMPASS Pathways plc COMPASS Pathways plc Healthcare 7.8644 1.65 0 -1.91 -0.69 0
#2 Alkermes plc Alkermes plc Healthcare 7.7698 3.32 3.13 13.27 9.4 0
#3 Relmada Therapeutics, Inc. Relmada Therapeutics, Inc. Healthcare 6.6722 0.39 0 -0.21 -0.12 0
#4 GH Research PLC GH Research PLC Healthcare 6.1726 2.04 0 -17.08 -6.96 0
#5 Neurocrine Biosciences Neurocrine Biosciences Healthcare 5.8272 5.49 6.03 41.64 22.57 0
#6 Supernus Pharmaceuticals, Inc. Supernus Pharmaceuticals, Inc. Healthcare 5.2346 0.0027 3.92 -73.08 1941.46 0
#7 Alto Neuroscience, Inc. Alto Neuroscience, Inc. Healthcare 5.0798 1.93 0 -1.26 -2.06 0
#8 AbbVie AbbVie Healthcare 4.6133 92.87 6.6 95.5 25.13 2.98
#9 Johnson & Johnson Johnson & Johnson Healthcare 4.3527 7.21 6.24 21.94 13.34 2.79
#10 NRx Pharmaceuticals, Inc. NRx Pharmaceuticals, Inc. Healthcare 3.5295 -0.69 0 -1.21 -1.15 0
#11 NewMarket Corporation NewMarket Corporation Vor. Industrials 3.186 3.48 1.83 11 8 1.55
#12 Neuronetics, Inc. Neuronetics, Inc. Healthcare 2.5719 1.48 0.63 -2.77 -3.22 0
#13 Silo Pharma, Inc. Silo Pharma, Inc. Healthcare 1.0227 0.79 55.35 -0.72 -0.36 0

Zahlen Sie das Abonnement

Weitere Funktionen und Daten zur Analyse von Unternehmen und Portfolio sind nach Abonnement verfügbar